Skip to main content

Medical Practice Variations in Diabetes Mellitus

  • Reference work entry
  • First Online:
Medical Practice Variations

Part of the book series: Health Services Research ((HEALTHSR))

Abstract

Diabetes mellitus is a serious chronic health condition that has a global impact on both individuals and healthcare systems. In 2013, approximately 382 million people worldwide were living with diabetes, and it is expected that over 590 million people (∼10 % of the world’s population) will be living with diabetes by 2035. Most recently, an estimated US$548 billion were spent globally on diabetes care. Beyond the enormous financial burden of diabetes, individuals living with diabetes are prone to numerous health risks and complications. Diabetes not only reduces an individual’s life expectancy but also increases the risk of heart disease, kidney disease, eye disease, limb amputations, and other complications. There are cost-effective treatment approaches to help reduce the risk of these devastating complications; however, the uptake of these evidence-based treatments is not consistent across geographic regions. In this chapter, medical practice variation is reviewed within the context of access to and provision of high-quality diabetes care. This chapter briefly reviews the therapeutics of diabetes, including the epidemiology, diagnosis, pathogenesis, and management of diabetes. The bulk of the chapter then focuses on describing the current state of medical practice variation research in diabetes, and the systematic interventions have been put in place to increase the quality of care and potentially reduce unwarranted practice variation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 279.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agency for Healthcare Research and Quality. National healthcare quality report 2012. Rockville: U.S. Department of Health and Human Services; 2013.

    Book  Google Scholar 

  • Alberti H, Boudriga N, Nabli M. Variations in care in diabetes in primary care centres in Tunis. Diabet Metab. 2004;30:197–200.

    Article  CAS  Google Scholar 

  • Ali MK, Bullard KM, Saaddine JB, et al. Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med. 2013;368:1613–24.

    Article  CAS  PubMed  Google Scholar 

  • Amed S, Dean HJ, Panagiotopoulos C, et al. Type 2 diabetes, medication-induced diabetes, and monogenic diabetes in Canadian children. Diabetes Care. 2010;33:786–91.

    Article  PubMed  PubMed Central  Google Scholar 

  • American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2009;32 Suppl 1:S62–7.

    Article  PubMed Central  Google Scholar 

  • American Diabetes Association. Standards of medical care in diabetes – 2014. Diabetes Care. 2013;37:S14–80.

    Article  Google Scholar 

  • American Diabetes Association Workgroup on Hypoglycemia. Defining and reporting hypoglycemia in diabetes. Diabetes Care. 2005;28:1245–9.

    Article  Google Scholar 

  • Andrus MR, Kelley KW, Murphey LM, Herndon KC. A comparison of diabetes care in rural and urban medical clinics in Alabama. J Community Health. 2004;29:29–44.

    Article  PubMed  Google Scholar 

  • Arday DR, Fleming BB, Keller DK, et al. Variation in diabetes care among states: do patient characteristics matter? Diabetes Care. 2002;25:2230–7.

    Article  PubMed  Google Scholar 

  • Aro S, Koivisto VA, Reunanen A, Salinto M, Kangas T. Influence of morbidity and health care structure on hospitalization among adult diabetic patients. Diabet Med. 1996;13:376–81.

    Article  CAS  PubMed  Google Scholar 

  • Asghari S, Courteau J, Orzanco M, Vanasse A. Do geographical disparities affect the pattern of medication use in diabetic patients? Can J Diabetes. 2009;33:228.

    Article  Google Scholar 

  • Bergman U, Elmes P, Halse M, et al. The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol. 1975;8:83–9.

    Article  CAS  PubMed  Google Scholar 

  • Berkowitz SA, Gerstenblith G, Herbert R, Anderson G. Improving regional variation using quality of care measures. Risk Manag Healthc Policy. 2009;2:91–96.

    Article  PubMed  PubMed Central  Google Scholar 

  • Booth GL, Hux JE. Relationship between avoidable hospitalizations for diabetes mellitus and income level. Arch Intern Med. 2003;163:101–6.

    Article  PubMed  Google Scholar 

  • Booth GL, Zinman B, Redelmeier DA. Diabetes care in the U.S. and Canada. Diabetes Care. 2002;25:1149–53.

    Article  PubMed  Google Scholar 

  • Booth GL, Hux JE, Fang J, Chan BTB. Time trends and geographic disparities in acute complications of diabetes in Ontario. Can Diabetes Care. 2005;28:1045–50.

    Article  PubMed  Google Scholar 

  • Borchers AT, Uibo R, Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun Rev. 2010;9:A355–65.

    Article  PubMed  Google Scholar 

  • Bowker S, Majumdar S, Johnson J. Systematic review of indicators and measurements used in controlled studies of quality improvement for type 2 diabetes. Can J Diabetes. 2005;29:230–8.

    Google Scholar 

  • Braga M, Casanova A, Teoh H, et al. Treatment gaps in the management of cardiovascular risk factors in patients with type 2 diabetes in Canada. Can J Cardiol. 2010;26:297–302.

    Article  PubMed  PubMed Central  Google Scholar 

  • Brahm N, McKee J, Steward D. Diabetes mellitus. In: DiPrio JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posy LM, editors. Pharmacotherapy a pathophysiologic approach. 8th ed. Toronto: McGraw-Hill; 2011.

    Google Scholar 

  • Brown LJ, Barnett JR. Influence of bed supply and health care organization on regional and local patterns of diabetes related hospitalization. Soc Sci Med. 1992;35:1157–70.

    Article  CAS  PubMed  Google Scholar 

  • Campbell SM, Braspenning J, Hutchinson A, Marshall M. Research methods used in developing and applying quality indicators in primary care. Qual Saf Health Care. 2002;11:358–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Campbell SM, Reeves D, Kontopantelis E, Sibbald B, Roland M. Effects of pay for performance on the quality of primary care in England. N Engl J Med. 2009;361:368–78.

    Article  CAS  PubMed  Google Scholar 

  • Canadian Diabetes Association. An economic tsunami, the cost of diabetes in Canada. Toronto: Canadian Diabetes Association; 2009.

    Google Scholar 

  • Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes. 2013;37 Suppl 1:S1–212.

    Article  Google Scholar 

  • Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes in the United States. Atlanta: US Department of Health and Human Services/Centers for Disease Control and Prevention; 1997.

    Google Scholar 

  • Chan BT, Harju M. Supply and utilization of health services for diabetes. In: Hux J, Booth G, Slaughter P, Laupacis A, editors. Diabetes Australia and the National Health and Medical Research Council. Toronto: Institute for Clinical Evaluative Sciences; 2003. p. 14.249–14.68.

    Google Scholar 

  • Chen H-F, Wang C-Y, Lee H-Y, et al. Short-term case fatality rate and associated factors among inpatients with diabetic ketoacidosis and hyperglycemic hyperosmolar state: a hospital-based analysis over a 15-year period. Intern Med. 2010;49:729–37.

    Article  PubMed  Google Scholar 

  • Chiasson J, Aris-Jilwan N, Bélanger R, et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ. 2003;168:859–66.

    PubMed  PubMed Central  Google Scholar 

  • Chudyk A, Petrella R. Effects of exercise on cardiovascular risk factors in type 2 diabetes. Diabetes Care. 2011;34:1228–37.

    Article  PubMed  PubMed Central  Google Scholar 

  • Colagiuri S, Dickinson S, Girgis S, Colagiuri R. National evidence based guideline for blood glucose control in type 2 diabetes. Diabetes Australia and the NHMRC. Canberra; 2009.

    Google Scholar 

  • Colberg SR, Sigal RJ, Fernhall B, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement. Diabetes Care. 2010;33:e147–67.

    Article  PubMed  PubMed Central  Google Scholar 

  • Connell FA, Blide LA, Hanken MA. Clinical correlates of small area variations in population-based admission rates for diabetes. Med Care. 1984;22:939–49.

    Article  CAS  PubMed  Google Scholar 

  • Cook CB, Elias B, Kongable GL, et al. Diabetes and hyperglycemia quality improvement efforts in hospitals in the United States: current status, practice variation, and barriers to implementation. Endocr Pract. 2010;16:219–30.

    Article  PubMed  Google Scholar 

  • Curtis JR, To T, Muirhead S, Cummings E, Daneman D. Recent trends in hospitalization for diabetic ketoacidosis in Ontario children. Diabetes Care. 2002;25:1591–6.

    Article  PubMed  Google Scholar 

  • Danaei G, Finucane MM, Lu Y, et al. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet. 2011;378:31–40.

    Article  CAS  PubMed  Google Scholar 

  • De Berardis G, Pellegrini F, Franciosi M, et al. Quality of care and outcomes in type 2 diabetic patients: a comparison between general practice and diabetes clinics. Diabetes Care. 2004;27:398–406.

    Article  PubMed  Google Scholar 

  • Diabetes Epidemiology Research International Mortality Study Group. Major cross-country differences in risk of dying for people with IDDM. Diabetes Care. 1991;14:49–54.

    Article  Google Scholar 

  • Donabedian A. Evaluating the quality of medical care. 1966. Milbank Q. 2005;83:691–729.

    Article  PubMed  PubMed Central  Google Scholar 

  • Donnelly LA, Morris AD, Frier BM, et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated type 2 diabetes: a population-based study. Diabet Med. 2005;22:749–55.

    Article  CAS  PubMed  Google Scholar 

  • Doran T, Kontopantelis E. Pay-for-performance: impact on diabetes. Curr Diab Rep. 2013;13:196–204.

    Article  PubMed  Google Scholar 

  • Driskell OJ, Holland D, Hanna FW, et al. Inappropriate requesting of glycated hemoglobin (Hb A1c) is widespread: assessment of prevalence, impact of national guidance, and practice-to-practice variability. Clin Chem. 2012;58:906–15.

    Article  CAS  PubMed  Google Scholar 

  • Duckworth W, Abraira C, Moritz T, et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med. 2009;360:129–39.

    Article  CAS  PubMed  Google Scholar 

  • Efstathiou SP, Tsiakou AG, Tsioulos DI, et al. A mortality prediction model in diabetic ketoacidosis. Clin Endocrinol. 2002;57:595–601.

    Article  Google Scholar 

  • Egede LE, Gebregziabher M, Hunt KJ, et al. Regional, geographic, and racial/ethnic variation in glycemic control in a national sample of veterans with diabetes. Diabetes Care. 2011;34:938–43.

    Article  PubMed  PubMed Central  Google Scholar 

  • EURODIAB ACE Study Group. Variation and trends in incidence of childhood diabetes in Europe. Lancet. 2000;355:873–6.

    Article  Google Scholar 

  • Felner EI, Klitz W, Ham M, et al. Genetic interaction among three genomic regions creates distinct contributions to early- and late-onset type 1 diabetes mellitus. Pediatr Diabetes. 2005;6:213–20.

    Article  PubMed  Google Scholar 

  • Feltbower RG, Bodansky HJ, Patterson CC, et al. Acute complications and drug misuse are important causes of death for children and young adults with type 1 diabetes. Diabetes Care. 2008;31:922–6.

    Article  PubMed  Google Scholar 

  • Fishbein H, Palumbo P, editors. Acute metabolic complications in diabetes. 2nd ed. Bethesda: National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases; 1995.

    Google Scholar 

  • Fleming BB, Greenfield S, Engelgau MM, et al. The Diabetes Quality Improvement Project: moving science into health policy to gain an edge on the diabetes epidemic. Diabetes Care. 2001;24:1815–20.

    Article  CAS  PubMed  Google Scholar 

  • Flodgren G, Eccles MP, Shepperd S, et al. An overview of reviews evaluating the effectiveness of financial incentives in changing healthcare professional behaviours and patient outcomes. Cochrane Database Syst Rev. 2011:7:CD009255.

    Google Scholar 

  • Forlenza GP, Rewers M. The epidemic of type 1 diabetes: what is it telling us? Curr Opin Endocrinol Diabetes Obes. 2011;18:248–51.

    Article  PubMed  Google Scholar 

  • Gaede P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383–93.

    Article  PubMed  Google Scholar 

  • Gaede P, Lund-Andersen H, Parving H, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med. 2008;358:580–91.

    Article  CAS  PubMed  Google Scholar 

  • Garber AJ, Abrahamson MJ, Barzilay JI, et al. American Association of Clinical Endocrinologists’ comprehensive diabetes management algorithm 2013 consensus statement. Endocr Pract. 2013;19:1–48.

    Article  Google Scholar 

  • Gellad WF, Good CB, Lowe JC, Donohue JM. Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System. Am J Manag Care. 2010;16:741–50.

    PubMed  PubMed Central  Google Scholar 

  • Gerstein HC, Miller ME, Byington RP, et al. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358:2545–59.

    Article  CAS  PubMed  Google Scholar 

  • Glazier R, Creatore M, Gozdyra P, Weyman J, Booth G. Access to health resources. In: Glazier R, Booth G, Gozdyra P, Creatore M, Tynan A, editors. Neighbourhood environments and resources for health living – a focus on diabetes in Toronto. Toronto: Institute for Clinical Evaluative Sciences; 2007. p. 272–84.

    Google Scholar 

  • Goldenberg RM, Cheng AY, Punthakee Z, Clement M. Use of glycated hemoglobin (A1C) in the diagnosis of type 2 diabetes mellitus in adults. Can J Diabetes. 2011;35:247–9.

    Article  Google Scholar 

  • Griffiths K, McDevitt DG, Andrew M, et al. Validation of observed differences in the utilization of antihypertensive and antidiabetic drugs in Northern Ireland, Norway and Sweden. Eur J Clin Pharmacol. 1985;29:1–8.

    Article  CAS  PubMed  Google Scholar 

  • Griffiths K, McDevitt DG, Andrew M, et al. Therapeutic traditions in Northern Ireland, Norway and Sweden: I. Diabetes. WHO Drug Utilization Research Group (DURG). Eur J Clin Pharmacol. 1986;30:513–9.

    Article  CAS  PubMed  Google Scholar 

  • Gulliford M, Figueroa-Munoz J, Morgan M, et al. What does ‘access to health care’ mean? J Health Serv Res Policy. 2002;7:186–8.

    Article  PubMed  Google Scholar 

  • Gulliford MC, Charlton J, Latinovic R. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion? J Hum Hypertens. 2005;19:111–7.

    Article  CAS  PubMed  Google Scholar 

  • Guzman JR, Lyra R, Aguilar-Loza N, et al. Treatment of type 2 diabetes in Latin America: a consensus statement by the medical associations of 17 Latin American countries. Rev Saude Publica. 2010;28:463–71.

    Google Scholar 

  • Haller MJ, Atkinson MA, Schatz D. Type 1 diabetes mellitus: etiology, presentation, and management. Pediatr Clin North Am. 2005;52:1553–78.

    Article  PubMed  Google Scholar 

  • Hamblin P, Topliss D, Chosich N, Lording D, Stockigt J. Deaths associated with diabetic ketoacidosis and hyperosmolar coma. 1973–1988. Med J Aust. 1989;151:439–44.

    CAS  PubMed  Google Scholar 

  • Henriksen OM, Prahl JB, Roder ME, Svendsen OL. Treatment of diabetic ketoacidosis in adults in Denmark: a national survey. Diabetes Res Clin Pract. 2007;77:113–9.

    Article  PubMed  Google Scholar 

  • Hogan DB, Maxwell CJ, Fung TS, Ebly EM. Regional variation in the use of medications by older Canadians – a persistent and incompletely understood phenomena. Pharmacoepidemiol Drug Saf. 2003;12:575–82.

    Article  CAS  PubMed  Google Scholar 

  • Holleman F. Introduction. [Internet] 2013 [cited 2014 June 23]. Available from http://www.diapedia.org/introduction/1104085113/introduction

  • Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N Engl J Med. 2008;359:1577–89.

    Article  CAS  PubMed  Google Scholar 

  • Houle SK, McAlister FA, Jackevicius CA, Chuck AW, Tsuyuki RT. Does performance-based remuneration for individual health care practitioners affect patient care?: a systematic review. Ann Intern Med. 2012;157:889–99.

    Article  PubMed  Google Scholar 

  • Institute of Medicine. Health, health care, and quality of care. In: Lohr KN, editor. Medicare: a strategy for quality assurance. Washington, DC: National Academy Press; 1990:19–44.

    Google Scholar 

  • Institute of Medicine. In: Millman MPD, editor. A Model for Monitoring Access. Access to health care in America. Washington, DC: The National Academies Press; 1993:31045.

    Google Scholar 

  • International Diabetes Federation. Global guideline for type 2 diabetes. Brussels: International Diabetes Federation; 2005.

    Google Scholar 

  • International Diabetes Federation. About diabetes. [Internet] 2014 [cited 2014 June 23]. Available from http://www.idf.org/about-diabetes

  • International Diabetes Federation. IDF Diabetes Atlas sixth edition. 2013 [cited 2014 June 23]. Available from http://www.idf.org/diabetesatlas

  • Ivers N, Jamtvedt G, Flottorp S, et al. Audit and feedback: effects on professional practice and healthcare outcomes. Cochrane Database Syst Rev. 2012;6:Cd000259.

    PubMed  Google Scholar 

  • Ivers NM, Tricco AC, Taljaard M, et al. Quality improvement needed in quality improvement randomised trials: systematic review of interventions to improve care in diabetes. BMJ Open. 2013;3:e002727.

    Article  PubMed  PubMed Central  Google Scholar 

  • Jarosz-Chobot P, Polanska J, Szadkowska A, et al. Rapid increase in the incidence of type 1 diabetes in Polish children from 1989 to 2004, and predictions for 2010 to 2025. Diabetologia. 2011;54:508–15.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Johnson JA, McLeod L, Edwards A, Rabi D, Balko S. Diabetes and health care utilization in Alberta. In: Johnson JA, editor. Alberta diabetes atlas 2011. Edmonton: Institute of Health Economics; 2011.

    Google Scholar 

  • Kaul P, Johnson J, Ryan E, Chik C. Chapter 12: Gestational diabetes in Alberta. In: Johnson J, editor. Alberta diabetes atlas 2011. Edmonton: Institute of Health Economics; 2011.

    Google Scholar 

  • Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes. Diabetes Care. 2002;25:1862–8.

    Article  PubMed  Google Scholar 

  • Kirkbride K, Wallace N. Rural health clinics and diabetes-related primary care for Medicaid beneficiaries in Oregon. J Rural Health. 2009;25:247–52.

    Article  PubMed  Google Scholar 

  • Kitabchi AE, Umpierrez GE, Murphy MB, Kreisberg RA. Hyperglycemic crises in adult patients with diabetes. Diabetes Care. 2006;29:2739–48.

    Article  CAS  PubMed  Google Scholar 

  • Knowler W, Barrett-Connor E, Fowler S, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.

    Article  CAS  PubMed  Google Scholar 

  • Ko SH, Lee WY, Lee JH, et al. Clinical characteristics of diabetic ketoacidosis in Korea over the past two decades. Diabet Med. 2005;22:466–9.

    Article  PubMed  Google Scholar 

  • Kodama S, Tanaka S, Heianza Y, et al. Association between physical activity and risk of all-cause mortality and cardiovascular disease in patients with diabetes a meta-analysis. Diabetes Care. 2013;36:471–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Krein S, Hofer T, Kerr EA, Hayward R. Whom should we profile? Examining diabetes care practice variation among primary care providers, provider groups, and health care facilities. Health Serv Res. 2002;37:1159–80.

    Article  PubMed  PubMed Central  Google Scholar 

  • Kristensen JK, Bro F, Sandbaek A, et al. HbAlc in an unselected population of 4438 people with type 2 diabetes in a Danish county. Scand J Prim Health Care. 2001;19:241–6.

    Article  CAS  PubMed  Google Scholar 

  • Law MR, Cheng L, Dhalla IA, Heard D, Morgan SG. The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012;184:297–302.

    Article  PubMed  PubMed Central  Google Scholar 

  • Leese GP, Wild SH, Edmonds ME. Variation in practice: a useful measure or not? Looking at amputations and diabetes care. Pract Diabetes Int. 2011;28:7.

    Article  Google Scholar 

  • Lester H, Schmittdiel J, Selby J, et al. The impact of removing financial incentives from clinical quality indicators: longitudinal analysis of four Kaiser Permanente indicators. BMJ. 2010;340:c1898.

    Article  PubMed  PubMed Central  Google Scholar 

  • Lewis EJ, Hunsicker LG, Clarke WR, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N Engl J Med. 2001;345:851–60.

    Article  CAS  PubMed  Google Scholar 

  • Lin S, Lin J, Huang Y. Diabetic ketoacidosis: comparisons of patient characteristics, clinical presentations and outcomes today and 20 years ago. Chang Gung Med J. 2005;28:24–30.

    CAS  PubMed  Google Scholar 

  • Lipscombe LL, Austin PC, Manuel DG, et al. Income-related differences in mortality among people with diabetes mellitus. Can Med Assoc J. 2010;182:E1–17.

    Article  Google Scholar 

  • Lorincz IS, Lawson BC, Long JA. Provider and patient directed financial incentives to improve care and outcomes for patients with diabetes. Curr Diab Rep. 2013;13:188–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2095–128.

    Article  PubMed  Google Scholar 

  • Lyon AW, Higgins T, Wesenberg JC, Tran DV, Cembrowski GS. Variation in the frequency of hemoglobin A1c (HbA1c) testing: population studies used to assess compliance with clinical practice guidelines and use of HbA1c to screen for diabetes. J Diabetes Sci Technol. 2009;3:411–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Majumdar SR, Johnson JA, Bowker S, et al. A Canadian consensus for the standardized evaluation of quality improvement interventions in type 2 diabetes. Can J Diabetes. 2005;29:220–9.

    Google Scholar 

  • Margolis DJ, Hoffstad O, Nafash J, et al. Location, location, location: geographic clustering of lower-extremity amputation among Medicare beneficiaries with diabetes. Diabetes Care. 2011;34:2363–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Masharani U, German M. Pancreatic hormones and diabetes mellitus. In: Gardner D, Shoback D, editors. Greenspan’s basic & clinical endocrinology. 8th ed. McGraw-Hill Medical; United States of America, 2007.

    Google Scholar 

  • Matsushima M, LaPorte RE, Maruyama M, et al. Geographic variation in mortality among individuals with youth-onset diabetes mellitus across the world. Diabetologia. 1997;40:212–6.

    Article  CAS  PubMed  Google Scholar 

  • Mattke S, Epstein AM, Leatherman S. The OECD Health Care Quality Indicators Project: history and background. Int J Qual Health Care. 2006;18 Suppl 1:1–4.

    Article  PubMed  Google Scholar 

  • McBean AM, Huang Z, Virnig BA, Lurie N, Musgrave D. Racial variation in the control of diabetes among elderly medicare managed care beneficiaries. Diabetes Care. 2003;26:3250–6.

    Article  PubMed  Google Scholar 

  • McGinn J, Davis C. Geographic variation, physician characteristics, and diabetes care disparities in a metropolitan area, 2003–2004. Diabetes Res Clin Pract. 2006;72:162–9.

    Article  PubMed  Google Scholar 

  • Metzer B. Summary and recommendations of the third international conference on gestational diabetes mellitus. Diabetes. 1991;40:197–201.

    Article  Google Scholar 

  • Morbach S, Lutale JK, Viswanathan V, et al. Regional differences in risk factors and clinical presentation of diabetic foot lesions. Diabet Med. 2004;21:91–5.

    Article  CAS  PubMed  Google Scholar 

  • Morgan S, Raymond C, Mooney D, Martin D. The Canadian Rx atlas. 2nd ed. Vancouver: The Centre for Health Services and Policy Research; 2008.

    Google Scholar 

  • National Institute for Health and Clinical Excellence. Quality standards for diabetes in adults. 2011 [cited 2013 April 17]. Available from http://www.nice.org.uk/media/FCF/87/DiabetesInAdultsQualityStandard.pdf

  • Newton CA, Raskin P. Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences. Arch Intern Med. 2004;164:1925–31.

    Article  CAS  PubMed  Google Scholar 

  • Nyenwe E, Loganathan R, Blum S, et al. Admissions for diabetic ketoacidosis in ethnic minority groups in a city hospital. Metabolism. 2007;56:172–8.

    Article  CAS  PubMed  Google Scholar 

  • O’Brien MA, Rogers S, Jamtvedt G, et al. Educational outreach visits: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2007:4:CD000409.

    Google Scholar 

  • O’Connor PJ, Rush WA, Davidson G, et al. Variation in quality of diabetes care at the levels of patient, physician, and clinic. Prev Chronic Dis. 2008;5:A15.

    PubMed  PubMed Central  Google Scholar 

  • O’Connor PJ, Bodkin NL, Fradkin J, et al. Diabetes performance measures: current status and future directions. Diabetes Care. 2011;34:1651–9.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ohinmaa A, Jacobs P, Simpson S, Johnson J. The projection of prevalence and cost of diabetes in Canada: 2000 to 2016. Can J Diabetes. 2004;28:1–8.

    Google Scholar 

  • Onkamo P, Väänänen S, Karvonen M, Tuomilehto J. Worldwide increase in incidence of type I diabetes – the analysis of the data on published incidence trends. Diabetologia. 1999;42:1395–403.

    Article  CAS  PubMed  Google Scholar 

  • Otiniano M, Wood RC. Exploring the importance of identifying geographic variation to improve diabetes treatment. J Diabetes Complications. 2012;26:255–6.

    Article  PubMed  Google Scholar 

  • Parving H-H, Lehnert H, Bröchner-Mortensen J, et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. N Engl J Med. 2001;345:870–8.

    Article  CAS  PubMed  Google Scholar 

  • Patel A, MacMahon S, Chalmers J, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N Engl J Med. 2008;358:2560–72.

    Article  CAS  PubMed  Google Scholar 

  • Patrick S, Tajima N, LaPorte R, Kitagawa T. A comparison of renal disease mortality among individuals with Insulin-Dependent Diabetes Mellitus (IDDM) in Japan and Allegheny County, PA, the United States. J Jpn Diabet Soc. 1992;35:993–1000.

    Google Scholar 

  • Patterson CC, Dahlquist GG, Gyürüs E, Green A, Soltész G. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study. Lancet. 2009;373:2027–33.

    Article  PubMed  Google Scholar 

  • Payne CB, Scott RS. Hospital discharges for diabetic foot disease in New Zealand: 1980–1993. Diabetes Res Clin Pract. 1998;39:69–74.

    Article  CAS  PubMed  Google Scholar 

  • Pimouguet C, Le Goff M, Thiebaut R, Dartigues JF, Helmer C. Effectiveness of disease-management programs for improving diabetes care: a meta-analysis. CMAJ. 2011;183:E115–27.

    Article  PubMed  PubMed Central  Google Scholar 

  • Public Health Agency of Canada. Report from the National Diabetes Surveillance System: diabetes in Canada. Ottawa: Public Health Agency of Canada; 2009.

    Google Scholar 

  • Radley DC, Schoen C. Geographic variation in access to care – the relationship with quality. N Engl J Med. 2012;367:3–6.

    Article  CAS  PubMed  Google Scholar 

  • Raymond C, Metge C, Alessi-Severini S, et al. Pharmaceutical use in Manitoba: opportunities to optimize use. Winnipeg: Manitoba Centre for Health Policy; 2010.

    Google Scholar 

  • Rith-Najarian SJ, Gohdes DM, Shields R, et al. Regional variation in cardiovascular disease risk factors among American Indians and Alaska Natives with diabetes. Diabetes Care. 2002;25:279–83.

    Article  PubMed  Google Scholar 

  • Rose G, Duerksen F, Trepman E, et al. Multidisciplinary treatment of diabetic foot ulcers in Canadian Aboriginal and non-Aboriginal people. Foot Ankle Surg. 2008;14:74–81.

    Article  PubMed  Google Scholar 

  • Rother KI. Diabetes treatment – bridging the divide. N Engl J Med. 2007;356:1499–501.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Sargen MR, Hoffstad OJ, Wiebe DJ, Margolis DJ. Geographic variation in pharmacotherapy decisions for U.S. Medicare enrollees with diabetes. J Diabetes Complications. 2012;26:301–7.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sargen MR, Hoffstad O, Margolis DJ. Geographic variation in Medicare spending and mortality for diabetic patients with foot ulcers and amputations. J Diabetes Complications. 2013;27:128–33.

    Article  PubMed  PubMed Central  Google Scholar 

  • Schneider S, Bock C, Wetzel M, Maul H, Loerbroks A. The prevalence of gestational diabetes in advanced economies. J Perinat Med. 2012;40:511–520.

    Article  PubMed  Google Scholar 

  • Schuyler Jones W, Patel MR, Dai D, et al. Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000–2008. J Am Coll Cardiol. 2012;60:2230–6.

    Article  PubMed  PubMed Central  Google Scholar 

  • Scott A, Sivey P, Ait Ouakrim D, et al. The effect of financial incentives on the quality of health care provided by primary care physicians. Cochrane Database Syst Rev. 2011:9:CD008451.

    Google Scholar 

  • Shah BR, Hux JE, Laupacis A, et al. Diabetic patients with prior specialist care have better glycaemic control than those with prior primary care. J Eval Clin Pract. 2005;11:568–75.

    Article  PubMed  Google Scholar 

  • Shah ND, Montori VM, Krumholz HM, et al. Responding to an FDA warning – geographic variation in the use of rosiglitazone. N Engl J Med. 2010;363:2081–4.

    Article  CAS  PubMed  Google Scholar 

  • Shojania KG, Ranji SR, McDonald KM, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296:427–40.

    Article  CAS  PubMed  Google Scholar 

  • Si D, Bailie R, Wang Z, Weeramanthri T. Comparison of diabetes management in five countries for general and indigenous populations: an internet-based review. BMC Health Serv Res. 2010;10:169.

    Article  PubMed  PubMed Central  Google Scholar 

  • Skrivarhaug T, Bangstad HJ, Stene L, et al. Long-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway. Diabetologia. 2006;49:298–305.

    Article  CAS  PubMed  Google Scholar 

  • Skyler JS. Primary and secondary prevention of type 1 diabetes. Diabet Med. 2013;30:161–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Snorgaard O, Eskildsen P, Vadstrup S, Nerup J. Diabetic ketoacidosis in Denmark: epidemiology, incidence rates, precipitating factors and mortality rates. J Intern Med. 1989;226:223–8.

    Article  CAS  PubMed  Google Scholar 

  • Strauss K, MacLean C, Troy A, Littenberg B. Driving distance as a barrier to glycemic control in diabetes. J Gen Intern Med. 2006;21:378–80.

    Article  PubMed  PubMed Central  Google Scholar 

  • Tseng CL, Helmer D, Rajan M, et al. Evaluation of regional variation in total, major, and minor amputation rates in a national health-care system. Int J Qual Health Care. 2007;19:368–76.

    Article  PubMed  Google Scholar 

  • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329:977–86.

    Article  Google Scholar 

  • The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med. 2005;353:2643–53.

    Article  Google Scholar 

  • The Diamond Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990–1999. Diabet Med. 2006;23:857–66.

    Article  Google Scholar 

  • The Task Force on Cardiology, Cardiovascular Diseases of the European Society of Diabetes, of the European Association for the Study of Diabetes. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD). Eur Heart J. 2013;34:3035–87.

    Google Scholar 

  • Tricco AC, Ivers NM, Grimshaw JM, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379:2252–61.

    Article  PubMed  Google Scholar 

  • UKPDS Study Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998a;352:854–65.

    Article  Google Scholar 

  • UKPDS Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998b;352:837–53.

    Article  Google Scholar 

  • Usher C, Bennett K, Feely J. Evidence for a gender and age inequality in the prescribing of preventative cardiovascular therapies to the elderly in primary care. Age Ageing. 2004;33:500–2.

    Article  PubMed  Google Scholar 

  • Usher C, Bennett K, Feely J. Regional variation in the prescribing for diabetes and use of secondary preventative therapies in Ireland. Pharmacoepidemiol Drug Saf. 2005;14:537–44.

    Article  PubMed  Google Scholar 

  • Usher-Smith JA, Thompson MJ, Sharp SJ, Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: a systematic review. BMJ. 2011;343:d4092.

    Article  PubMed  PubMed Central  Google Scholar 

  • van Houtum WH, Lavery LA. Regional variation in the incidence of diabetes-related amputations in the Netherlands. Diabetes Res Clin Pract. 1996;31:125–32.

    Article  PubMed  Google Scholar 

  • Walsh MG, Zgibor J, Borch-Johnsen K, Orchard TJ. A multinational comparison of complications assessment in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 2. Diabetes Care. 2004;27:1610–7.

    Article  PubMed  Google Scholar 

  • Walsh MG, Zgibor J, Borch-Johnsen K, Orchard TJ. A multinational assessment of complications in type 1 diabetes: the DiaMond substudy of complications (DiaComp) level 1. Diab Vasc Dis Res. 2006;3:84–92.

    Article  PubMed  Google Scholar 

  • Weingarten Jr JP, Brittman S, Hu W, et al. The state of diabetes care provided to Medicare beneficiaries living in rural America. J Rural Health. 2006;22:351–8.

    Article  PubMed  Google Scholar 

  • Wennberg JE. Unwarranted variations in healthcare delivery: implications for academic medical centres. BMJ. 2002;325:961–4.

    Article  PubMed  PubMed Central  Google Scholar 

  • Wrobel JS, Mayfield JA, Reiber GE. Geographic variation of lower-extremity major amputation in individuals with and without diabetes in the Medicare population. Diabetes Care. 2001;24:860–4.

    Article  CAS  PubMed  Google Scholar 

  • Yusuf S, Hawken S, Ôunpuu S, et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. Lancet. 2004;364:937–52.

    Article  PubMed  Google Scholar 

  • Zgibor JC, Gieraltowski LB, Talbott EO, et al. The association between driving distance and glycemic control in rural areas. J Diabetes Sci Technol. 2011;5:494–500.

    Article  PubMed  PubMed Central  Google Scholar 

  • Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030. Diabetes Res Clin Pract. 2010;87:293–301.

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

Dr. Gamble is currently supported as a Canadian Institutes of Health Research New Investigator and a Canadian Diabetes Association Clinician Scientist.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John-Michael Gamble .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media New York

About this entry

Cite this entry

Gamble, JM., Butalia, S. (2016). Medical Practice Variations in Diabetes Mellitus. In: Johnson, A., Stukel, T. (eds) Medical Practice Variations. Health Services Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4899-7603-1_85

Download citation

  • DOI: https://doi.org/10.1007/978-1-4899-7603-1_85

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4899-7602-4

  • Online ISBN: 978-1-4899-7603-1

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics